The performance of PET/CT is better than standalone PET or CT in patients with cancer of the larynx. PET/CT had a major impact on management of 59% of patients.

Early dynamic blood flow FDG PET/CT may be used to help discriminate and characterize HCC tumors.

The division of thrombotic disorders into metabolically nonactive and active thrombus may be helpful for differential diagnosis of underlying diseases causing thrombus formation. IV contrast media administration during PET/CT makes it possible to visualize the thrombus itself and helps to distinguish between benign and malignant metabolically active thrombus.

No abstract

A wide spectrum of benign musculoskeletal disorders associated with focal FDG uptake may be detected in cancer patients. This incidental uptake usually does not seem to be a clinically significant finding, but it can affect quality of life.